|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.27 USD | -2.51% |
|
+0.89% | +1.00% |
| 25/03 | Recursion Pharmaceuticals Announces Executive Changes, Effective April 6, 2026 | CI |
| 11/03 | Exelixis, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 12:00 PM |
| Capitalization | 1.15TCr 979.46Cr 906.45Cr 853.49Cr 1.59TCr 1,06900Cr 1.62TCr 11TCr 4.16TCr 51TCr 4.31TCr 4.22TCr 1,83000Cr | P/E ratio 2026 * |
14.5x | P/E ratio 2027 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise value | 1.05TCr 892.24Cr 825.73Cr 777.49Cr 1.45TCr 97TCr 1.48TCr 9.69TCr 3.79TCr 47TCr 3.93TCr 3.85TCr 1,66700Cr | EV / Sales 2026 * |
4.05x | EV / Sales 2027 * | 3.22x |
| Free-Float |
98.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Exelixis, Inc.
| 1 day | -2.51% | ||
| 1 week | +0.89% | ||
| Current month | +3.22% | ||
| 1 month | +7.53% | ||
| 3 months | +0.48% | ||
| 6 months | +16.04% | ||
| Current year | +1.00% |
| 1 week | 43.75 | 45.56 | |
| 1 month | 40.84 | 45.56 | |
| Current year | 39.71 | 46.31 | |
| 1 year | 33.76 | 49.62 | |
| 3 years | 18.08 | 49.62 | |
| 5 years | 14.87 | 49.62 | |
| 10 years | 4.21 | 49.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 22/07/2010 | |
| Director of Finance/CFO | 58 | 15/07/2015 | |
Dana Aftab
COO | Chief Operating Officer | 63 | 01/02/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 01/02/2004 | |
George Poste
BRD | Director/Board Member | 82 | 01/08/2004 |
| Chairman | 77 | 01/01/1998 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.51% | +0.89% | +25.38% | +127.14% | 1.15TCr | ||
| -0.59% | +4.53% | +28.56% | +93.99% | 4.98TCr | ||
| +0.13% | +6.34% | +104.09% | +28.22% | 4.7TCr | ||
| -3.00% | -4.69% | +125.77% | +831.47% | 3.34TCr | ||
| +3.83% | +4.74% | -1.06% | -24.09% | 2.42TCr | ||
| -1.73% | +0.28% | +66.42% | -34.48% | 1.9TCr | ||
| -0.28% | +1.88% | +40.07% | -34.68% | 1.73TCr | ||
| -0.29% | +0.22% | +58.48% | +195.71% | 1.63TCr | ||
| +1.86% | +1.50% | -15.36% | +1,169.03% | 1.53TCr | ||
| -1.18% | +0.04% | +51.78% | - | 1.47TCr | ||
| Average | -0.38% | +1.48% | +48.41% | +261.37% | 2.48TCr | |
| Weighted average by Cap. | -0.37% | +2.34% | +57.23% | +233.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 258.37Cr 220.1Cr 203.7Cr 191.8Cr 357.25Cr 24TCr 364.57Cr 2.39TCr 935.02Cr 12TCr 969.59Cr 949.04Cr 41TCr | 293.09Cr 249.68Cr 231.07Cr 217.57Cr 405.26Cr 27TCr 413.56Cr 2.71TCr 1.06TCr 13TCr 1.1TCr 1.08TCr 47TCr |
| Net income | 80Cr 68Cr 63Cr 60Cr 110.99Cr 7.47TCr 113.27Cr 742.43Cr 290.5Cr 3.59TCr 301.24Cr 294.85Cr 13TCr | 98Cr 84Cr 78Cr 73Cr 136.05Cr 9.15TCr 138.84Cr 910.06Cr 356.09Cr 4.39TCr 369.25Cr 361.43Cr 16TCr |
| Net Debt | -102.38Cr -87Cr -81Cr -76Cr -141.56Cr -9.52TCr -144.46Cr -946.87Cr -370.49Cr -4.57TCr -384.19Cr -376.04Cr -16TCr | -205.62Cr -175.16Cr -162.11Cr -152.64Cr -284.31Cr -19TCr -290.13Cr -1.9TCr -744.11Cr -9.18TCr -771.62Cr -755.27Cr -33TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | 44.27 $ | -2.51% | 29,45,426 |
| 09/26/09 | 45.41 $ | +2.74% | 18,13,072 |
| 08/26/08 | 44.20 $ | +0.48% | 26,29,277 |
| 07/26/07 | 43.99 $ | +0.02% | 23,86,716 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EXEL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















